Search

Eric Olson

Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1693, 1673, 1623
Total Applications
1758
Issued Applications
971
Pending Applications
175
Abandoned Applications
632

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4682838 [patent_doc_number] => 20080249064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Activities of an active principle obtained from powdered alfalfa seeds (Medicago sativa), active principle used and process of obtaining the same' [patent_app_type] => utility [patent_app_number] => 11/902836 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3336 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249064.pdf [firstpage_image] =>[orig_patent_app_number] => 11902836 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/902836
Activities of an active principle obtained from powdered alfalfa seeds (Medicago sativa), active principle used and process of obtaining the same Sep 25, 2007 Abandoned
Array ( [id] => 4705133 [patent_doc_number] => 20080064657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Isomaltooligosaccharides from Leuconostoc as Neutraceuticals' [patent_app_type] => utility [patent_app_number] => 11/860845 [patent_app_country] => US [patent_app_date] => 2007-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9926 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064657.pdf [firstpage_image] =>[orig_patent_app_number] => 11860845 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/860845
Isomaltooligosaccharides from Leuconostoc as Neutraceuticals Sep 24, 2007 Abandoned
Array ( [id] => 5398309 [patent_doc_number] => 20090318372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Method For Producing 2-O-Glyceryl-Alpha-D-Glucopyranoside' [patent_app_type] => utility [patent_app_number] => 12/442288 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6074 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318372.pdf [firstpage_image] =>[orig_patent_app_number] => 12442288 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/442288
Method For Producing 2-O-Glyceryl-Alpha-D-Glucopyranoside Sep 20, 2007 Abandoned
Array ( [id] => 4939414 [patent_doc_number] => 20080076733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Pharmaceutical compositions and therapeutic applications for the use of a novel vitamin B12 derivative, N-acetyl-L-cysteinylcobalamin' [patent_app_type] => utility [patent_app_number] => 11/903066 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17413 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076733.pdf [firstpage_image] =>[orig_patent_app_number] => 11903066 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/903066
Pharmaceutical compositions and therapeutic applications for the use of a novel vitamin B12 derivative, N-acetyl-L-cysteinylcobalamin Sep 19, 2007 Issued
Array ( [id] => 4933462 [patent_doc_number] => 20080004237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'Polysacchocride prodrug of 5-fluorouracil (5-FU) with enhanced target specificity for galectin-3 expressing cancers' [patent_app_type] => utility [patent_app_number] => 11/657754 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7172 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20080004237.pdf [firstpage_image] =>[orig_patent_app_number] => 11657754 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/657754
Polysacchocride prodrug of 5-fluorouracil (5-FU) with enhanced target specificity for galectin-3 expressing cancers Sep 16, 2007 Abandoned
Array ( [id] => 5398321 [patent_doc_number] => 20090318384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/441808 [patent_app_country] => US [patent_app_date] => 2007-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2895 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318384.pdf [firstpage_image] =>[orig_patent_app_number] => 12441808 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/441808
COMPOSITION INTENDED FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Sep 16, 2007 Abandoned
Array ( [id] => 4705343 [patent_doc_number] => 20080064867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'PROCESS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 11/853662 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 27124 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064867.pdf [firstpage_image] =>[orig_patent_app_number] => 11853662 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/853662
Process for the synthesis of oligonucleotides Sep 10, 2007 Issued
Array ( [id] => 6444442 [patent_doc_number] => 20100144654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyl-oxy)-phenyl] hexane' [patent_app_type] => utility [patent_app_number] => 12/440300 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16046 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144654.pdf [firstpage_image] =>[orig_patent_app_number] => 12440300 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/440300
Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyl-oxy)-phenyl] hexane Sep 6, 2007 Abandoned
Array ( [id] => 4939594 [patent_doc_number] => 20080076913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Methods of synthesizing oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection' [patent_app_type] => utility [patent_app_number] => 11/899828 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12019 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076913.pdf [firstpage_image] =>[orig_patent_app_number] => 11899828 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/899828
Methods of synthesizing oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection Sep 5, 2007 Issued
Array ( [id] => 7724440 [patent_doc_number] => 08097711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Thioether substituted aryl carbonate protecting groups' [patent_app_type] => utility [patent_app_number] => 11/897898 [patent_app_country] => US [patent_app_date] => 2007-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 24830 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097711.pdf [firstpage_image] =>[orig_patent_app_number] => 11897898 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/897898
Thioether substituted aryl carbonate protecting groups Aug 30, 2007 Issued
Array ( [id] => 4771414 [patent_doc_number] => 20080057072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'ANTAGONISTS OF CI-M6P/IGF2R FOR PREVENTION AND TREATMENT OF CTGF-MEDIATED OCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/847523 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5064 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057072.pdf [firstpage_image] =>[orig_patent_app_number] => 11847523 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/847523
ANTAGONISTS OF CI-M6P/IGF2R FOR PREVENTION AND TREATMENT OF CTGF-MEDIATED OCULAR DISORDERS Aug 29, 2007 Abandoned
Array ( [id] => 4880392 [patent_doc_number] => 20080153775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'WEIGHT REDUCTION PROGRAM AND METHOD' [patent_app_type] => utility [patent_app_number] => 11/845131 [patent_app_country] => US [patent_app_date] => 2007-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3057 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153775.pdf [firstpage_image] =>[orig_patent_app_number] => 11845131 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/845131
WEIGHT REDUCTION PROGRAM AND METHOD Aug 26, 2007 Abandoned
Array ( [id] => 6511562 [patent_doc_number] => 20100261272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Compositions for Reducing Cell Adhesion to Bubbles' [patent_app_type] => utility [patent_app_number] => 12/438681 [patent_app_country] => US [patent_app_date] => 2007-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9232 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261272.pdf [firstpage_image] =>[orig_patent_app_number] => 12438681 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/438681
Compositions for reducing cell adhesion to bubbles Aug 26, 2007 Issued
Array ( [id] => 4734388 [patent_doc_number] => 20080051368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Process for the isolation and stabilization of low-molecular weight aminoglycans form waste egg shells' [patent_app_type] => utility [patent_app_number] => 11/895500 [patent_app_country] => US [patent_app_date] => 2007-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3383 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051368.pdf [firstpage_image] =>[orig_patent_app_number] => 11895500 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/895500
Process for the isolation and stabilization of low-molecular weight aminoglycans form waste egg shells Aug 26, 2007 Issued
Array ( [id] => 5231325 [patent_doc_number] => 20070293433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Methods of treating aging of skin with oligosaccharides in cosmetic or dermatological compositions that stimulate adhesion of keratinocytes to major proteins of the dermoepidermal junction and restore epidermal cohesion' [patent_app_type] => utility [patent_app_number] => 11/894945 [patent_app_country] => US [patent_app_date] => 2007-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3952 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293433.pdf [firstpage_image] =>[orig_patent_app_number] => 11894945 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/894945
Methods of treating aging of skin with oligosaccharides in cosmetic or dermatological compositions that stimulate adhesion of keratinocytes to major proteins of the dermoepidermal junction and restore epidermal cohesion Aug 21, 2007 Abandoned
Array ( [id] => 4803566 [patent_doc_number] => 20080015155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye' [patent_app_type] => utility [patent_app_number] => 11/841564 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7991 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20080015155.pdf [firstpage_image] =>[orig_patent_app_number] => 11841564 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/841564
Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye Aug 19, 2007 Abandoned
Array ( [id] => 6644311 [patent_doc_number] => 20100227834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'NUCLEOSIDES FOR SUPPRESSING OR REDUCING THE DEVELOPMENT OF RESISTANCE IN CYTOSTATIC THERAPY' [patent_app_type] => utility [patent_app_number] => 12/377239 [patent_app_country] => US [patent_app_date] => 2007-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27393 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227834.pdf [firstpage_image] =>[orig_patent_app_number] => 12377239 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/377239
Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy Aug 12, 2007 Issued
Array ( [id] => 853123 [patent_doc_number] => 07378508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Polymorphic crystalline forms of tiacumicin B' [patent_app_type] => utility [patent_app_number] => 11/831886 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12898 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378508.pdf [firstpage_image] =>[orig_patent_app_number] => 11831886 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/831886
Polymorphic crystalline forms of tiacumicin B Jul 30, 2007 Issued
Array ( [id] => 4688977 [patent_doc_number] => 20080033158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Multi layer chromatography of nucleic acids' [patent_app_type] => utility [patent_app_number] => 11/888490 [patent_app_country] => US [patent_app_date] => 2007-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4966 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20080033158.pdf [firstpage_image] =>[orig_patent_app_number] => 11888490 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/888490
Multi layer chromatography of nucleic acids Jul 30, 2007 Issued
Array ( [id] => 5199702 [patent_doc_number] => 20070299020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Methods for treatment of ovarian, colorectal or pancreatic cancer using 4-(aminno)-2(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione' [patent_app_type] => utility [patent_app_number] => 11/881756 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20185 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299020.pdf [firstpage_image] =>[orig_patent_app_number] => 11881756 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/881756
Methods for treatment of ovarian, colorectal or pancreatic cancer using 4-(aminno)-2(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione Jul 26, 2007 Abandoned
Menu